151 related articles for article (PubMed ID: 34618239)
1. Large and diffuse ductal carcinoma in situ: potentially lethal subtypes of "preinvasive" disease.
O'Keefe TJ; Harismendy O; Wallace AM
Int J Clin Oncol; 2022 Jan; 27(1):121-130. PubMed ID: 34618239
[TBL] [Abstract][Full Text] [Related]
2. Trends in the treatment of ductal carcinoma in situ of the breast.
Baxter NN; Virnig BA; Durham SB; Tuttle TM
J Natl Cancer Inst; 2004 Mar; 96(6):443-8. PubMed ID: 15026469
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for breast cancer mortality after ductal carcinoma in situ diagnosis differ from those for invasive recurrence.
O'Keefe TJ; Chau H; Harismendy O; Wallace AM
Surgery; 2023 Feb; 173(2):305-311. PubMed ID: 36435650
[TBL] [Abstract][Full Text] [Related]
4. Trends in Treatment Patterns and Outcomes for Ductal Carcinoma In Situ.
Worni M; Akushevich I; Greenup R; Sarma D; Ryser MD; Myers ER; Hwang ES
J Natl Cancer Inst; 2015 Dec; 107(12):djv263. PubMed ID: 26424776
[TBL] [Abstract][Full Text] [Related]
5. Association of Radiotherapy With Survival in Women Treated for Ductal Carcinoma In Situ With Lumpectomy or Mastectomy.
Giannakeas V; Sopik V; Narod SA
JAMA Netw Open; 2018 Aug; 1(4):e181100. PubMed ID: 30646103
[TBL] [Abstract][Full Text] [Related]
6. Association of Regional Intensity of Ductal Carcinoma In Situ Treatment With Likelihood of Breast Preservation.
Punglia RS; Cronin AM; Uno H; Stout NK; Ozanne EM; Greenberg CC; Frank ES; Schrag D
JAMA Oncol; 2017 Jan; 3(1):101-104. PubMed ID: 27442038
[TBL] [Abstract][Full Text] [Related]
7. Long-term Survival Comparison of Repeated Breast-conserving Surgery Versus Mastectomy for Patients with DCIS with Ipsilateral Breast Tumor Recurrence: A Real-world Longitudinal Study.
Li Q; Wang K; Yang L; Wu Q; Zhu W; Li Z; Shi Y; Zhang X; Li H
Clin Breast Cancer; 2021 Aug; 21(4):360-372. PubMed ID: 33846099
[TBL] [Abstract][Full Text] [Related]
8. Association of a Diagnosis of Ductal Carcinoma In Situ With Death From Breast Cancer.
Giannakeas V; Sopik V; Narod SA
JAMA Netw Open; 2020 Sep; 3(9):e2017124. PubMed ID: 32936299
[TBL] [Abstract][Full Text] [Related]
9. Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ.
Narod SA; Iqbal J; Giannakeas V; Sopik V; Sun P
JAMA Oncol; 2015 Oct; 1(7):888-96. PubMed ID: 26291673
[TBL] [Abstract][Full Text] [Related]
10. HER2-Overexpressing Ductal Carcinoma
O'Keefe TJ; Blair SL; Hosseini A; Harismendy O; Wallace AM
Cancer Prev Res (Phila); 2020 Sep; 13(9):761-772. PubMed ID: 32493703
[TBL] [Abstract][Full Text] [Related]
11. The impact of surgery on ductal carcinoma in situ outcomes: the use of mastectomy.
Hwang ES
J Natl Cancer Inst Monogr; 2010; 2010(41):197-9. PubMed ID: 20956829
[TBL] [Abstract][Full Text] [Related]
12. Ductal carcinoma in situ (DCIS) treated by mastectomy, or local excision with or without radiotherapy: A monocentric, retrospective study of 608 women.
Frank S; Dupont A; Teixeira L; Porcher R; De Roquancourt A; Giacchetti S; Espié M; Cuvier C
Breast; 2016 Feb; 25():51-6. PubMed ID: 26573444
[TBL] [Abstract][Full Text] [Related]
13. Contralateral breast cancer after curative-intent treatment for ductal carcinoma in situ: Rate and associated clinicopathological and imaging risk factors.
Hovis K; Mercaldo S; Kim G; Lamb LR; Oseni TO; Bahl M
Clin Imaging; 2022 Feb; 82():179-192. PubMed ID: 34872008
[TBL] [Abstract][Full Text] [Related]
14. Trends in Unilateral and Contralateral Prophylactic Mastectomy Use in Ductal Carcinoma In Situ of the Breast: Patterns and Predictors.
Zhang B; Coopey SB; Gadd MA; Hughes KS; Chang DC; Oseni TO
Ann Surg Oncol; 2019 Nov; 26(12):3863-3873. PubMed ID: 31325048
[TBL] [Abstract][Full Text] [Related]
15. Subsequent risk of ipsilateral and contralateral invasive breast cancer after treatment for ductal carcinoma in situ: incidence and the effect of radiotherapy in a population-based cohort of 10,090 women.
Elshof LE; Schaapveld M; Schmidt MK; Rutgers EJ; van Leeuwen FE; Wesseling J
Breast Cancer Res Treat; 2016 Oct; 159(3):553-63. PubMed ID: 27624164
[TBL] [Abstract][Full Text] [Related]
16. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.
Vargas C; Kestin L; Go N; Krauss D; Chen P; Goldstein N; Martinez A; Vicini FA
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1514-21. PubMed ID: 16005576
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS.
Wapnir IL; Dignam JJ; Fisher B; Mamounas EP; Anderson SJ; Julian TB; Land SR; Margolese RG; Swain SM; Costantino JP; Wolmark N
J Natl Cancer Inst; 2011 Mar; 103(6):478-88. PubMed ID: 21398619
[TBL] [Abstract][Full Text] [Related]
18. Association of DCIS size and margin status with risk of developing breast cancer post-treatment: multinational, pooled cohort study.
Schmitz RSJM; van den Belt-Dusebout AW; Clements K; Ren Y; Cresta C; Timbres J; Liu YH; Byng D; Lynch T; Menegaz BA; Collyar D; Hyslop T; Thomas S; Love JK; Schaapveld M; Bhattacharjee P; Ryser MD; Sawyer E; Hwang ES; Thompson A; Wesseling J; Lips EH; Schmidt MK;
BMJ; 2023 Oct; 383():e076022. PubMed ID: 37903527
[TBL] [Abstract][Full Text] [Related]
19. Ductal Carcinoma In Situ - Quo Vadis?
Peltecu G
Chirurgia (Bucur); 2021 Dec; 116(5 Suppl):S5-S6. PubMed ID: 34967322
[TBL] [Abstract][Full Text] [Related]
20. The Role of Intraoperative Pathologic Assessment in the Surgical Management of Ductal Carcinoma In Situ.
Decker MR; Trentham-Dietz A; Loconte NK; Neuman HB; Smith MA; Punglia RS; Greenberg CC; Wilke LG
Ann Surg Oncol; 2016 Sep; 23(9):2788-94. PubMed ID: 27026436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
